Home  |  Contact

UniProtKB/Swiss-Prot Q07889: Variant p.Trp729Leu

Son of sevenless homolog 1
Gene: SOS1
Variant information

Variant position:  729
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Tryptophan (W) to Leucine (L) at position 729 (W729L, p.Trp729Leu).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from large size and aromatic (W) to medium size and hydrophobic (L)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -2
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In NS4; promotes constitutive RAS activation and enhances ERK activation.
Any additional useful information about the variant.



Sequence information

Variant position:  729
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  1333
The length of the canonical sequence.

Location on the sequence:   YLLQRMEEFIGTVRGKAMKK  W VESITKIIQRKKIARDNGPG
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         YLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPG

Mouse                         DLLQRMEEFIGTVRGKAMKKWVESITKIIQRKKIARDNGPG

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 1 – 1333 Son of sevenless homolog 1
Domain 597 – 741 N-terminal Ras-GEF
Alternative sequence 372 – 1333 Missing. In isoform 2.
Helix 727 – 741


Literature citations

Gain-of-function SOS1 mutations cause a distinctive form of Noonan syndrome.
Tartaglia M.; Pennacchio L.A.; Zhao C.; Yadav K.K.; Fodale V.; Sarkozy A.; Pandit B.; Oishi K.; Martinelli S.; Schackwitz W.; Ustaszewska A.; Martin J.; Bristow J.; Carta C.; Lepri F.; Neri C.; Vasta I.; Gibson K.; Curry C.J.; Lopez Siguero J.P.; Digilio M.C.; Zampino G.; Dallapiccola B.; Bar-Sagi D.; Gelb B.D.;
Nat. Genet. 39:75-79(2007)
Cited for: VARIANTS NS4 LYS-108; ARG-269; ARG-432; LYS-433; TYR-441; ARG-548; PRO-550; GLY-552; LYS-552; SER-552; HIS-702; LEU-729; PHE-733 AND LYS-846; VARIANTS LEU-655; ARG-977 AND ARG-1320; CHARACTERIZATION OF VARIANTS NS4 GLY-552 AND LEU-729;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.